𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma

✍ Scribed by Hiroyuki Yamamoto; Shouhei Iku; Fumio Itoh; Xiufen Tang; Masao Hosokawa; Kohzoh Imai

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
550 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Human leukocyte antigen-G expression is
Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
✍ Aifen Lin; Xia Zhang; Wen-Jun Zhou; Yan-Yun Ruan; Dan-Ping Xu; Qing Wang; Wei-Hu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 485 KB πŸ‘ 1 views

## Abstract Human leukocyte antigen **(**HLA)‐G inhibits functions of immune component cells and promotes malignant cells evading from antitumor immunity. We investigated the clinical relevance of HLA‐G expression in esophageal squamous cell carcinoma (ESCC). In our study, HLA‐G expression in 79 pr

EphA2 overexpression correlates with poo
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
✍ Tatsuya Miyazaki; Hiroyuki Kato; Minoru Fukuchi; Masanobu Nakajima; Hiroyuki Kuw πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 370 KB πŸ‘ 1 views

## Abstract EphA2 is a member of the Eph family of receptor tyrosine kinases, which interact with cell‐bound ligands known as ephrins. EphA2 expression was investigated by immunohistochemistry with an anti‐EphA2 monoclonal antibody in 80 patients with esophageal squamous cell carcinoma (ESCC) who h

High expression of EZH2 is associated wi
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
✍ Li-Ru He; Meng-Zhong Liu; Bin-Kui Li; Wei-Hua Jia; Ying Zhang; Yi-Ji Liao; Yang- πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 498 KB πŸ‘ 1 views

## Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinom